1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
OpenText said it will buy up to $300,000,000 of its 3.875% Senior Notes due 2028 in a cash tender offer, but holders tendered $697,563,000, so purchases are prorated at 43.047752%. The company expects a concurrent senior secured notes offering to close on October 1, 2026, with proceeds and cash on hand used to redeem its 6.900% Senior Secured Notes due 2027 and to pay for the tendered 2028 notes. The filing concerns debt refinancing and does not report earnings or guidance.
Accepts up to $300,000,000 aggregate principal; $697,563,000 principal tendered; proration factor 43.047752%.
Tender Offer Consideration of $981.71 per $1,000 principal, set at a fixed spread of +50 basis points over the 4.250% U.S. Treasury due February 15, 2028 (reference yield 4.773%).
Tender expired 5:00 p.m. New York City time on September 30, 2026; settlement expected October 2, 2026.
Concurrent senior secured notes offering expected to close October 1, 2026, to fund the redemption of the 6.900% Senior Secured Notes due 2027.
Sagimet Biosciences agreed on September 30, 2026 to sell 8,750,010 shares of Series A common stock at $10.00 per share and pre-funded warrants for up to 2,750,010 shares, with net proceeds expected to be $107.5 million. The company plans to use the proceeds with its existing cash to fund a Phase 3 trial of denifanstat in acne, pre-launch activities, and other clinical and corporate needs, and the offering is expected to close on October 1, 2026.
8,750,010 common shares offered at $10.00 per share, plus pre-funded warrants for up to 2,750,010 shares
Expected net proceeds of $107.5 million after underwriting discounts and commissions
Offering expected to close October 1, 2026, subject to customary closing conditions
Underwriters include Leerink Partners LLC, TD Securities (USA) LLC and Guggenheim Securities, LLC as representatives
On September 30, 2026, Solana Company agreed to sell 4,369,356 Class A shares at $3.433 each to a single institutional investor, with warrants for the same number of shares at $3.776. Gross proceeds are expected to be about $15 million, or about $14.3 million net, and the offering is expected to close on or about October 1, 2026. The issuance adds new shares that existing shareholders will share in, and the company plans to use the proceeds to accumulate SOL, buy back stock, and for working capital and other purposes.
4,369,356 Class A shares sold at $3.433 per share, with warrants for up to 4,369,356 shares at $3.776 per share
Gross proceeds about $15 million; net proceeds about $14.3 million; placement agent cash fee of 4.0% of gross proceeds
Shares priced at a 5% premium to net asset value per share; company reported total NAV of $278 million as of September 24, 2026, with SOL at $119
Closing expected on or about October 1, 2026; Clear Street served as exclusive placement agent
Cheetah Net Supply Chain Service Inc. disclosed progress on its at-the-market share sale program with Pacific Century Securities, which allows sales of Class A common stock of up to $35.3 million. As of September 25, 2026, the company had sold about 196,850,000 shares under the program, before the reverse split took effect on September 28, 2026. After the 1-for-150 reverse split, the company reports about 1,332,087 Class A and 1,358 Class B shares outstanding, a much smaller share count for existing holders.
ATM Offering authorizes sales of Class A common stock with an aggregate offering price of up to $35.3 million, under an agreement entered August 21, 2026
About 196,850,000 shares sold under the ATM Offering as of September 25, 2026, before giving effect to the reverse split
1-for-150 reverse split of Class A and Class B common stock became market effective September 28, 2026
After the split, about 1,332,087 Class A and 1,358 Class B shares are issued and outstanding
KLX Energy Services completed its subscription rights offering on September 29, 2026, selling 24,975,001 shares at $1.49 each for $37.2 million in gross proceeds. Backstop holders of its 2030 Notes exchanged them for 59,273,445 shares, cutting outstanding principal by $94.0 million, and the company expects 105,677,168 shares outstanding afterward, so existing shareholders will be diluted. The 2030 Notes indenture was also amended to loosen leverage tests, which gives the company more covenant flexibility.
Rights offering: 24,975,001 shares sold at $1.49 per share for $37.2 million gross; $31.0 million for general corporate purposes and $6.2 million to redeem 2030 Notes at par on October 10, 2026
Backstop exchange: 59,273,445 shares issued to Backstop Parties; 2030 Notes principal reduced by $94.0 million; 105,677,168 shares expected outstanding
Indenture amended: total net leverage incurrence test relaxed from 2.50:1.00 to 3.00:1.00; maintenance covenant step-down reset to 4.50:1.00 starting with the quarter ending September 30, 2026
Immix Biopharma agreed on September 29, 2026 to sell 11,363,637 shares of common stock at $11.00 per share in an underwritten offering led by J.P. Morgan Securities LLC. The company expects gross proceeds of $125 million and net proceeds of approximately $117.1 million, with closing expected on September 30, 2026. The company plans to use the proceeds for NXC-201 development, working capital and general corporate purposes.
11,363,637 shares priced at $11.00 per share under an underwriting agreement with J.P. Morgan Securities LLC dated September 29, 2026
Expected gross proceeds of $125 million and net proceeds of approximately $117.1 million after underwriting discounts, commissions and offering expenses
Offering expected to close on or about September 30, 2026, subject to customary conditions; proceeds to fund NXC-201 development, working capital and general corporate purposes
Reed's entered an amendment to its senior secured loan with Whitebox-affiliated lenders and Cantor Fitzgerald as agent, converting its revolving credit commitments into $9.25 million of term loans that cannot be re-borrowed once repaid. The amendment raises the interest rate to 8.75% from 8.00%, extends maturity to June 30, 2027, and adds a new Event of Default requiring at least $10 million of cash equity contributions by November 6, 2026, which matters to shareholders because it signals tighter financing terms and a near-term capital requirement.
Revolving credit commitments converted into $9.25 million in term loans, effective September 30, 2026
Interest rate on term loans rises to 8.75% per annum from 8.00%; optional extension period accrues at 9.25%
Maturity extended to June 30, 2027, with an optional three-month extension to September 30, 2027
New Event of Default requires at least $10 million in cash equity contributions by November 6, 2026; inventory plus receivables liquidity covenant waived through that date
Beasley Broadcast Group closed a registered direct offering and a concurrent private placement on September 30, 2026, selling 200,000 Class A shares at $14.00 each, pre-funded warrants for up to 157,000 shares, and common warrants for 357,000 shares exercisable at $15.00. The company expects net proceeds of about $4.3 million, which it plans to use with proceeds from asset sales to reduce revolver borrowings and redeem part of its 11.000% notes due 2028, but the sales add shares and warrants that could dilute existing shareholders.
200,000 Class A shares sold at $14.00 each to a single institutional investor, plus pre-funded warrants for up to 157,000 shares
Common warrants for 357,000 shares at a $15.00 exercise price, initially exercisable six months after issuance
Net proceeds of about $4.3 million after a 6.0% placement agent fee; about $2.2 million to reduce revolver borrowings and about $11.4 million to redeem 11.000% notes due 2028
Company agreed not to issue more equity for 60 days and not to enter variable rate transactions for 180 days after the September 30, 2026 closing
Bridgford Foods signed a 45-day extension of its revolving line of credit with Wells Fargo Bank, moving the maturity date to November 13, 2026, on existing terms. The filing indicates the company can borrow up to $7.5 million under the line, which is a routine financing step that keeps short-term borrowing capacity in place.
Maturity extended by 45 days to November 13, 2026, on existing terms
Credit line allows borrowing of up to $7,500,000
Interest at bank prime rate or secured overnight financing rate plus 2.0%; unused commitment fee of 0.25%
Carriage Services entered a five-year, $300 million senior secured revolving credit facility led by JPMorgan Chase, which replaces its $250 million facility, and terminated its $100 million at-the-market equity offering program effective October 4, 2026. The company says the new facility lowers borrowing costs and adds liquidity, and that it is lowering its targeted leverage range to 3.0x–3.5x. The facility is secured by a first-priority lien on substantially all company and subsidiary guarantor assets.
Revolving credit facility of up to $300 million, with an optional $100 million accordion feature that no lender is obligated to fund
Replaces the $250 million facility from May 2021; the company says the new facility expands capacity and reduces borrowing spreads
$100 million at-the-market equity program terminated effective October 4, 2026
Targeted leverage ratio lowered from 3.5x–4.0x to 3.0x–3.5x; $400 million of 4.25% Senior Notes mature in May 2029
On September 29, 2026, BioStem Technologies agreed to sell 735,296 shares at $4.08 per share, with Series A and Series B warrants, for approximately $3.0 million in gross proceeds before fees; the deal closed September 30, 2026. The filing also says a $10.0 million Clearance Payment owed to BioTissue, due by September 15, 2026, has not been made, and the company is in ongoing talks about its timing and terms. Shareholders face potential dilution from the new shares and warrants, along with an unpaid obligation.
735,296 shares at $4.08 per share, plus Series A and Series B warrants each for up to 735,296 shares at a $3.83 exercise price
Gross proceeds of approximately $3.0 million before placement agent fees; H.C. Wainwright received a cash fee of 7.0% of gross proceeds
Private placement closed September 30, 2026; resale registration statement due within 30 calendar days of the registration rights agreement
$10.0 million Clearance Payment to BioTissue was due by September 15, 2026 and had not been paid as of the filing date
KULR Technology Group announced on X that it has extended the pause of its at-the-market equity offering program with Cantor Fitzgerald and Craig-Hallum through December 31, 2026. The filing is a Regulation FD disclosure and reports no new financial results, but it means the company is not selling new shares through this program for a longer period.
The at-the-market equity offering program with Cantor Fitzgerald and Craig-Hallum remains paused.
The pause has been extended through December 31, 2026.
The announcement was made on September 30, 2026 through the company's X account, @kulrtech.
CTO Realty Growth entered into a $1.0 billion amended and restated unsecured credit agreement with KeyBank as administrative agent, dated September 29, 2026, replacing its prior facility. Proceeds repaid its previous $300 million revolving credit facility and two term loans of $100 million each due in January 2027 and January 2028. The company says the deal extends debt maturities to 2029 through 2032 and adds $250 million of commitments, which lengthens its weighted average debt maturity to 4.3 years from 1.6 years, excluding extension options.
Facilities total $1.0 billion: a $400 million revolver due September 2030 with two six-month extension options, plus four $150 million term loans due September 2029, September 2030, September 2031 and March 2032
Total commitments increase by $250 million, with an accordion feature allowing up to $1.5 billion in aggregate commitments
Initial fixed rates after SOFR swaps are 5.3% (2029 loan), 4.9% (2030 loan), 4.8% (2031 loan) and 3.4% (2032 loan), with the 2032 rate adjusting to about 5.3% in February 2027
Company is subject to customary restrictive covenants and financial maintenance covenants
Burke & Herbert Financial Services Corp. completed a $100 million public offering of 7.00% fixed-to-floating rate subordinated notes due October 1, 2036, with the offering priced at 100% of principal. The company plans to use the proceeds, plus cash on hand, to repay several existing subordinated notes and potentially redeem part of its 2021 Preferred Stock, and to provide capital to its bank subsidiary.
$100.0 million of 7.00% fixed-to-floating rate subordinated notes due October 1, 2036, sold at 100% of principal through Keefe, Bruyette & Woods, Inc.
Fixed 7.00% interest until October 1, 2031, then floating at Three-Month Term SOFR plus 222 basis points
Proceeds plus cash on hand earmarked to repay $4.5 million 2028 note, $18.1 million July 2030 notes and $20.0 million October 2030 notes, and potentially repay $75.0 million of 3.25% notes due 2031
Offering expected to close September 30, 2026; notes intended to qualify as Tier 2 capital
On September 30, 2026, Vroom Automotive, LLC, a Vroom subsidiary, issued 16,000 Series A1 and 4,000 Series B1 preferred units to SPE Holdings 2026-1 for $20 million in gross proceeds. The units carry quarterly preferential distributions tied to SOFR plus 8.50% or 9.25%, and the Series B1 units are convertible into common units of Vroom Automotive at SPE Holdings' option. Vroom Automotive expects to use the proceeds to repay certain obligations and to purchase residual interests in certain asset-backed securitization trusts.
Gross proceeds of $20,000,000 from 16,000 Series A1 and 4,000 Series B1 preferred units
Distribution rate resets quarterly at 90-day average SOFR plus 8.50% (Series A1) or 9.25% (Series B1)
Series B1 units are convertible into common units at SPE Holdings' option; Series A1 units are not convertible
Agreement and A&R LLC Agreement dated September 30, 2026, filed as exhibits 10.1 and 10.2
CalciMedica filed a prospectus supplement covering the sale of up to $25,000,000 of its common stock through an at-the-market offering agreement with H.C. Wainwright & Co. The filing sets up a possible share sale program but does not state that any shares have been sold or at what price. Because new shares could dilute existing holders, the filing is relevant to shareholders.
Up to $25,000,000 of common stock may be sold under the at-the-market offering agreement dated August 11, 2023
Sales are made under shelf registration Form S-3 (No. 333-293972), filed March 3, 2026 and declared effective March 11, 2026
Cooley LLP legal opinion on the legality of the shares is filed as Exhibit 5.1
Nomad Power Solutions entered a Note Purchase Agreement on September 28, 2026, issuing a $6.57 million original issue discount secured promissory note for $6.0 million in gross proceeds. The note matures 12 months after funding, carries 9% annual interest, and is secured by company assets including equity interests, equipment, and receivables, with subsidiaries Lixte and Liora guaranteeing the debt, which may dilute or pressure shareholders' claim priority.
Gross proceeds of $6.0 million; original issue discount of $540,000 plus $30,000 in fees and expenses
Note matures 12 months from the Purchase Price Date and bears 9% annual interest
From the 6-month anniversary, the investor may redeem up to $800,000 per calendar month in cash, with 2 trading days to pay
Collateral includes all company equity interests, goods and equipment, accounts receivable, and contract rights; subsidiaries Lixte and Liora guarantee the debt
Lantern Pharma sold 3,669,725 shares or pre-funded warrants at $1.09 per share in a registered direct offering that closed on September 30, 2026, for approximately $4.0 million in gross proceeds before expenses. The company also issued unregistered warrants for up to 3,669,725 shares at $1.09 that could bring in about $4 million more if fully exercised, which would add to the number of shares outstanding and dilute existing shareholders.
Offering priced at $1.09 per share, with approximately $4.0 million in gross proceeds before expenses; closed September 30, 2026
Purchase warrants for up to 3,669,725 shares at $1.09 exercise price; exercisable only after stockholder approval, expiring five years after that approval
Company must seek stockholder approval within 90 days of September 28, 2026
Placement agent Rodman & Renshaw received a cash fee of 7% of gross proceeds, and the company plans to use net proceeds for working capital and general corporate purposes
Sonoco Products entered into a first amendment to its credit agreement on September 25, 2026, adding two term loan facilities totaling $800 million. It borrowed $500 million on the closing date and used it to refinance an existing $500 million term loan that was due in August 2028, with the remaining $300 million available for future refinancings.
New $400 million Tranche A term loan matures December 31, 2029, with no scheduled payments before maturity
New $400 million Tranche B delayed-draw term loan matures December 31, 2031; $100 million drawn at closing and $300 million remaining
$500 million borrowed on September 25, 2026 refinances an existing $500 million syndicated term loan scheduled to mature in August 2028
Interest margins are tied to senior unsecured debt ratings from S&P and/or Moody's
TD SYNNEX amended its trade receivables securitization program on September 25, 2026, extending the maturity to September 25, 2028 and raising lender commitments to $3.0 billion. The filing also lowers the program fee rates on used commitments to 0.725% (commercial paper funded) and 0.825% (other funding), and the lenders received an upfront fee.
Maturity extended to September 25, 2028
Aggregate lender commitment increased to $3,000,000,000
Program fee on used portion set at 0.725% per annum for commercial paper funding and 0.825% for other funding
Lenders were paid an upfront fee; the filing does not state its amount
Digimarc agreed on September 29, 2026 to sell 4,500,000 common shares at $4.04 per share in a registered direct offering, with gross proceeds expected to be about $18.2 million and closing expected on or about September 30, 2026. The company plans to use the net proceeds for general corporate purposes, and the filing adds investor participation rights in future equity offerings and a limit on most new share issuance through December 31, 2026, which shareholders should weigh alongside the new share count.
4,500,000 common shares offered at $4.04 per share; gross proceeds expected to be about $18.2 million
Closing expected on or about September 30, 2026, subject to customary closing conditions
Needham & Company acted as sole placement agent; shares sold under an S-3 registration statement declared effective July 13, 2026
Investors get participation rights in future equity offerings until the earlier of the third anniversary of closing or when the two most recent quarters show positive EBIT and operating cash flow
Rent the Runway launched a $15 million rights offering on September 30, 2026, giving eligible Class A stockholders the right to buy additional shares. Holders who keep their shares can use the rights to buy shares at $3.55 each, and the rights expire on October 14, 2026 unless extended.
Rights offering size: $15 million, launched September 30, 2026
Record date: 5:00 p.m. New York City time on September 25, 2026; each share held received one right
Each right entitles the holder to buy approximately 0.1251 Class A shares at $3.55 per share; no fractional shares will be issued
Rights expire at 5:00 p.m. New York City time on October 14, 2026, unless extended
Indaptus Therapeutics agreed on September 29, 2026 to extend the outside date for the closing of its $24.0 million private placement of common stock from September 29 to October 16, 2026. The notices and consents also let the company defer closing until purchaser closing conditions are met or waived, and extend the purchasers' funding deadline and related termination rights to the same date. For shareholders, the filing shows the financing has not yet closed and its timing now depends on the extended deadline.
Private placement of common stock with aggregate gross proceeds of approximately $24.0 million, before offering expenses, agreed on September 8, 2026
Outside date extended from September 29, 2026 to October 16, 2026 for each purchaser
Company may defer closing until purchaser closing conditions are satisfied or waived, but no later than October 16, 2026, unless otherwise agreed in writing
All other terms of the Purchase Agreement remain unchanged
Trump Media & Technology Group (TMTG) and TAE Technologies signed an amended and restated convertible promissory note that replaces a December 18, 2025 note tied to their pending all-stock merger. The amended note carries an initial $200 million first tranche, allows up to an additional $100 million second tranche, and caps total principal at $300 million plus PIK interest, so TMTG's financial exposure to TAE rises if the second tranche is drawn. The companies also filed a Form S-4 registration statement for the merger, which has not yet become effective.
First tranche principal is $200 million; TAE may request up to $100 million more during a second tranche draw period.
Second tranche draw period ends on the earlier of November 29, 2026 or termination of the merger agreement; each drawdown must be at least $50 million.
Interest accrues at 7% per year and is paid in kind by adding to principal; accrued interest under the note was $10,969,863.01 as of signing.
The note converts automatically on a qualified TAE financing of at least $300 million, and TMTG gets pre-conversion voting rights tied to 25% of the outstanding amount.
PowerCompute said its Bitcoin-backed credit facility with Arch Lending was settled on September 24, 2026, its scheduled reset date, and was not triggered by a margin call or forced liquidation. The company says secured debt fell about 94%, from about $19.4 million at June 30, 2026 to about $1.25 million, and that no Bitcoin remains pledged, which it expects to lower interest and collar-related expense.
Arch facility settled September 24, 2026, with $21,892,132 principal, $118,582 accrued interest and a $440,122 fee covered by sale of about 267.3 of 307 pledged Bitcoin
About 39.6 Bitcoin returned to the company; no Bitcoin remains pledged as collateral
Secured debt fell from about $19.4 million at June 30, 2026 to about $1.25 million, a reduction of about 94%
Remaining secured promissory note matures December 31, 2026 and is not secured by Bitcoin
Power Solutions International (PSI) entered a new $220 million committed revolving credit agreement with HSBC as administrative agent, maturing September 25, 2029, and used part of it to repay in full its prior $135 million facility with Standard Chartered Bank. The new facility carries a lower borrowing spread of SOFR plus 1.80% versus SOFR plus 2.60% under the prior facility, and the company borrowed $35.0 million at closing, which shareholders may track as new debt secured by substantially all company and guarantor assets.
Committed capacity rises from $135 million to $220 million, with a $70 million letter of credit sublimit and expiry on September 25, 2029.
Borrowing rate is SOFR plus 1.80% per annum, down from SOFR plus 2.60% under the prior facility.
The company borrowed $35.0 million at closing and repaid about $15.1 million under the prior facility, with no early termination penalties.
Covenants require an interest coverage ratio of at least 3.00 to 1.00 and a leverage ratio of no more than 3.00 to 1.00, tested quarterly; a change of control default applies under specified Weichai conditions.
Pitney Bowes and its subsidiaries amended their credit agreement on September 29, 2026, reducing the interest rate margin on $585.5 million of tranche B term loans by 75 basis points. The company expects the change to cut annual interest expense by about $4 million, and the March 2032 maturity and other terms are unchanged.
Tranche B term loans outstanding of $585.5 million; margin cut from 375 to 300 basis points over Term SOFR, or 3.00%, and 2.00% for Base Rate loans
Company expects annual interest expense to fall by about $4 million based on the current principal balance
Maturity date (March 2032) and other loan terms unchanged, per the press release
S&P Global Ratings upgraded the issuer credit rating to 'BB-' from 'B+'
Hyperscale Data and its subsidiaries signed an amendment on September 29, 2026 to their existing loan agreement with JGB-affiliated lenders. Affiliate Ault & Company borrowed an additional $21 million and issued notes totaling $22,580,645, and the maturity of all loans under the agreement was extended to December 14, 2027. The added debt is secured by collateral owned by the guarantors, and the proceeds are to fund a loan to Rockwell One Holdings secured by a Georgia manufacturing facility.
Ault & Company, an affiliate of the Company, borrowed an additional $21 million and issued secured notes totaling $22,580,645 to the lenders.
Maturity of all loans under the Loan Agreement extended to December 14, 2027.
Additional loan is secured by collateral from certain Hyperscale guarantors, including mortgages on owned properties; Milton C. Ault, III and Scott Soura also agreed to guarantee repayment of the notes.
Ault & Company intends to lend the proceeds to Rockwell One Holdings, secured by a first-priority leasehold mortgage on a LaGrange, Georgia property.
On September 28, 2026, Addentax Group Corp. agreed to sell 520,834 shares of common stock at $4.80 per share to Chan Kai Sang, for gross proceeds of approximately $2.5 million. The company plans to use the net proceeds for general corporate purposes, including working capital and potential strategic investments. The closing is subject to customary conditions, and the shares are unregistered, which means the sale adds to the number of shares outstanding.
Private placement agreements dated September 28, 2026, with Chan Kai Sang
520,834 shares at $4.80 per share, for about $2.5 million in gross proceeds
Shares not registered under the Securities Act; issued under Regulation S to non-U.S. persons, with closing subject to customary conditions
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.